Galderma to Present New Findings From Innovative Product Portfolio at the 2022 VCS Annual Symposium
Galderma, the leading company solely dedicated to advancing the future of dermatology, announced...
Read More
Tag: Galderma
Galderma Receives FDA Approval for Restylane® Defyne for Chin Augmentation
Galderma announces that the U.S. Food and Drug Administration (FDA) has...
Read More
Clinical study shows high level of patient satisfaction with Restylane® Kysse™
Galderma have unveiled results from an innovative open-label post-marketing study which assessed...
Read MoreGalderma Announces FDA Approval of Restylane® Lyft For Midface Injection via Cannula
Galderma Laboratories, L.P., a global leader focused on medical solutions in skin health, announced that it has received U.S. Food and Drug Administration (FDA) approval for the use of Restylane Lyft®, a...
Read MoreGalderma Announces Results of the Phase 4 ALAMO Study
Galderma, a global leader focused on medical solutions for skin health, announces the publication of results from the Phase 4 ALAMO study, which evaluated the efficacy and safety of Epiduo®...
Read MoreGalderma Granted FDA Approval for New Indication for Restylane® Lyft
Now indicated for Correction of Age Related Volume Loss in the Cheek Area. Galderma, a global healthcare company focused on skin health, announced today that it has received US Food...
Read MoreGalderma Receives FDA Approval for New Antibiotic-Free Treatment Option for Acne Patients
Galderma Laboratories, L.P. have announced that the U.S. Food and Drug Administration (FDA) approved antibiotic-free Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5%, for the once-daily, topical treatment of acne...
Read MoreGalderma receives FDA approval of novel treatment option for rosacea patients
Soolantra® (ivermectin) Cream, 1% found to be well tolerated with powerful results seen as early as two weeks
Read More
Nov/Dec Issue
